CABG versus PCI in multilesional vessel disease

Yi Chih Wang; Juey Jen Hwang; Jiunn Lee Lin

doi:10.1007/978-3-319-26515-5_15

CABG versus PCI in multilesional vessel disease

Yi Chih Wang, Juey Jen Hwang, Jiunn Lee Lin

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

With numerous trials conducted during the 1970s and 1980s evaluating coronary artery bypass surgery (CABG) versus medical treatment for patients with coronary artery disease (CAD), the absolute benefi t of surgery was shown to be prominent especially for those with more extensive coronary involvement. However, the pronounced effect of CABG for patients with multivessel CAD (MVD) has faced continuing challenges since the introduction of percutaneous coronary intervention (PCI) and evolving revascularization technology, such as coronary stents.

Original language	English
Title of host publication	Coronary Graft Failure
Subtitle of host publication	State of the Art
Publisher	Springer International Publishing
Pages	161-165
Number of pages	5
ISBN (Electronic)	9783319265155
ISBN (Print)	9783319265131
DOIs	https://doi.org/10.1007/978-3-319-26515-5_15
Publication status	Published - Jan 1 2016
Externally published	Yes

Keywords

Bare metal stent (BMS)
Coronary artery bypass surgery (CABG)
Coronary artery disease (CAD)
Drugeluting stent (DES)
Multivessel disease (MVD)
Percutaneous coronary intervention (PCI)
Percutaneous transluminal coronary angioplasty (PTCA)
Revascularization

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-3-319-26515-5_15

Cite this

@inbook{15bd88e09adf42a298e6fdcd75423b2e,

title = "CABG versus PCI in multilesional vessel disease",

abstract = "With numerous trials conducted during the 1970s and 1980s evaluating coronary artery bypass surgery (CABG) versus medical treatment for patients with coronary artery disease (CAD), the absolute benefi t of surgery was shown to be prominent especially for those with more extensive coronary involvement. However, the pronounced effect of CABG for patients with multivessel CAD (MVD) has faced continuing challenges since the introduction of percutaneous coronary intervention (PCI) and evolving revascularization technology, such as coronary stents.",

keywords = "Bare metal stent (BMS), Coronary artery bypass surgery (CABG), Coronary artery disease (CAD), Drugeluting stent (DES), Multivessel disease (MVD), Percutaneous coronary intervention (PCI), Percutaneous transluminal coronary angioplasty (PTCA), Revascularization",

author = "Wang, {Yi Chih} and Hwang, {Juey Jen} and Lin, {Jiunn Lee}",

note = "Publisher Copyright: {\textcopyright} Springer International Publishing Switzerland 2016.",

year = "2016",

month = jan,

day = "1",

doi = "10.1007/978-3-319-26515-5_15",

language = "English",

isbn = "9783319265131",

pages = "161--165",

booktitle = "Coronary Graft Failure",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - CABG versus PCI in multilesional vessel disease

AU - Wang, Yi Chih

AU - Hwang, Juey Jen

AU - Lin, Jiunn Lee

N1 - Publisher Copyright: © Springer International Publishing Switzerland 2016.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - With numerous trials conducted during the 1970s and 1980s evaluating coronary artery bypass surgery (CABG) versus medical treatment for patients with coronary artery disease (CAD), the absolute benefi t of surgery was shown to be prominent especially for those with more extensive coronary involvement. However, the pronounced effect of CABG for patients with multivessel CAD (MVD) has faced continuing challenges since the introduction of percutaneous coronary intervention (PCI) and evolving revascularization technology, such as coronary stents.

AB - With numerous trials conducted during the 1970s and 1980s evaluating coronary artery bypass surgery (CABG) versus medical treatment for patients with coronary artery disease (CAD), the absolute benefi t of surgery was shown to be prominent especially for those with more extensive coronary involvement. However, the pronounced effect of CABG for patients with multivessel CAD (MVD) has faced continuing challenges since the introduction of percutaneous coronary intervention (PCI) and evolving revascularization technology, such as coronary stents.

KW - Bare metal stent (BMS)

KW - Coronary artery bypass surgery (CABG)

KW - Coronary artery disease (CAD)

KW - Drugeluting stent (DES)

KW - Multivessel disease (MVD)

KW - Percutaneous coronary intervention (PCI)

KW - Percutaneous transluminal coronary angioplasty (PTCA)

KW - Revascularization

UR - http://www.scopus.com/inward/record.url?scp=84978254085&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978254085&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-26515-5_15

DO - 10.1007/978-3-319-26515-5_15

M3 - Chapter

AN - SCOPUS:84978254085

SN - 9783319265131

SP - 161

EP - 165

BT - Coronary Graft Failure

PB - Springer International Publishing

ER -

CABG versus PCI in multilesional vessel disease

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this